Teva To Cooperate With South Korean Handok Pharmaceuticals

Israeli pharmaceutical giant Teva has agreed to establish a joint venture with South Korean pharmaceutical company Handok. Teva will have a 51 percent stake in the venture, and will be in charge of manufacturing and supplying medicine. Handok will market, sell and distribute the products. The South Korean pharmaceutical market is estimated to be worth $14 billion.